Assignee
CELULARITY INC
US·13 granted patents·59 pending applications·9 citations·filing 2013–2025
Top patents by PatentIndex Score
72 records- 0183US11090339B2Treatment of pain using placental stem cellsCELULARITY INC·Filed 2019·Granted Aug 17, 2021·1 cites·15 claims
- 0281US9974840B2Human placental collagen compositions, and methods of making and using the sameCELULARITY INC·Filed 2013·Granted May 22, 2018·3 cites·12 claims
- 0380US10113146B2Method of collecting placental stem cellsCELULARITY INC·Filed 2016·Granted Oct 30, 2018·1 cites·24 claims
- 0480US10105399B2Methods and compositions for treatment of bone defects with placental cell populationsCELULARITY INC·Filed 2016·Granted Oct 23, 2018·2 cites·20 claims
- 0579US2023090316A1Treatment of premature birth complicationsCELULARITY INC·Filed 2022·Application pending·0 cites
- 0677US2022096352A1Human placental collagen compositions and methods of making and using the sameCELULARITY INC·Filed 2021·Application pending·0 cites
- 0776US10041043B2Method of producing erythrocytes without feeder cellsCELULARITY INC·Filed 2015·Granted Aug 7, 2018·1 cites·10 claims
- 0876US2023310319A1Cultivation of placenta to isolate exosomesCELULARITY INC·Filed 2023·Application pending·0 cites
- 0975US2022259563A1Methods of generating natural killer cellsCELULARITY INC·Filed 2022·Application pending·0 cites
- 1075US2023081199A1Enhanced placental stem cells and uses thereofCELULARITY INC·Filed 2022·Application pending·0 cites
- 1175US2022096564A1Methods and compositions for treatment of bone defects with placental cell populationsCELULARITY INC·Filed 2021·Application pending·0 cites
- 1274US11180731B2Methods of treating acute myeloid leukemia and multiple myeloma using natural killer cellsCELULARITY INC·Filed 2017·Granted Nov 23, 2021·1 cites·18 claims
- 1373US2020188446A1Renovation and Repopulation of Decellularized Tissues and Cadaveric Organs by Stem CellsCELULARITY INC·Filed 2020·Application pending·0 cites
- 1473US2021253327A1Devices and methods for thawing biological materialCELULARITY INC·Filed 2021·Application pending·0 cites
- 1572US11723930B2Treatment of inflammatory diseases using placental stem cellsCELULARITY INC·Filed 2020·Granted Aug 15, 2023·0 cites·5 claims
- 1670US2023142803A1Natural killer cells and ilc3 cells and uses thereofCELULARITY INC·Filed 2022·Application pending·0 cites
- 1769US2019376027A1Composition for collecting and preserving placental stem cells and methods of using the compositionCELULARITY INC·Filed 2019·Application pending·0 cites
- 1868US11696930B2Use of placental stem cells in treatment of acute kidney injuryCELULARITY INC·Filed 2019·Granted Jul 11, 2023·0 cites·11 claims
- 1968US2022348875A1Genetically modified natural killer cellsCELULARITY INC·Filed 2021·Application pending·0 cites
- 2067US11512282B2Enhanced placental stem cells and uses thereofCELULARITY INC·Filed 2019·Granted Nov 29, 2022·0 cites·15 claims
- 2167US2022072063A1Treatment of diabetic peripheral neuropathy using placental cellsCELULARITY INC·Filed 2021·Application pending·0 cites
- 2266US2023302058A1Treatment of lymphedema and related conditions using placental adherent cellsCELULARITY INC·Filed 2023·Application pending·0 cites
- 2366US2021032596A1Method of producing erythrocytesCELULARITY INC·Filed 2020·Application pending·0 cites
- 2466US2019089124A1Human placental collagen compositions and methods of making and using the sameCELULARITY INC·Filed 2018·Application pending·0 cites
- 2564US10590381B2Composition for collecting and preserving placental stem cells and methods of using the compositionCELULARITY INC·Filed 2017·Granted Mar 17, 2020·0 cites·20 claims
- 2664US10329529B2Enhanced placental stem cells and uses thereofCELULARITY INC·Filed 2014·Granted Jun 25, 2019·0 cites·17 claims
- 2764US2020009199A1Cytotherapeutics, Cytotherapeutic Units and Methods for Treatments Using ThemCELULARITY INC·Filed 2019·Application pending·0 cites
- 2864US2021230546A1Methods for isolation of plateletsCELULARITY INC·Filed 2021·Application pending·0 cites
- 2963US2019321413A1Treatment of premature birth complicationsCELULARITY INC·Filed 2019·Application pending·0 cites
- 3063US2019330592A1Methods of generating natural killer cellsCELULARITY INC·Filed 2019·Application pending·0 cites
- 3163US2021289769A1Cell composition and methods of making the sameCELULARITY INC·Filed 2021·Application pending·0 cites
- 3263US2025295776A1Cleavage resistant cd16 constructs and uses thereofCELULARITY INC·Filed 2023·Application pending·0 cites
- 3363US2022241347A1Placenta-derived adherent cell exosomes and uses thereofCELULARITY INC·Filed 2021·Application pending·0 cites
- 3462US11173182B1Placenta-derived adherent cell exosomes and uses thereofCELULARITY INC·Filed 2020·Granted Nov 16, 2021·0 cites·14 claims
- 3562US2021002606A1Extracellular matrix composition beads for cell cultureCELULARITY INC·Filed 2020·Application pending·0 cites
- 3662US2018233218A1Systems and methods for providing a stem cell bankCELULARITY INC·Filed 2018·Application pending·0 cites
- 3762US2019262406A1Methods and compositions for treatment of bone defects with placental cell populationsCELULARITY INC·Filed 2018·Application pending·0 cites
- 3862US2025276063A1Placenta-dervied nk cells as a senol ytic for therapeutic and other usesCELULARITY INC·Filed 2022·Application pending·0 cites
- 3961US2021145872A1Methods of tissue generationCELULARITY INC·Filed 2020·Application pending·0 cites
- 4061US2019307686A1Cultivation of placenta to isolate exosomesCELULARITY INC·Filed 2018·Application pending·0 cites
- 4160US2020246393A1Tumor suppression using human placenta-derived intermediate natural killer (pink) cells in combination with an antibodyCELULARITY INC·Filed 2018·Application pending·0 cites
- 4260US2019152676A1Devices and methods for thawing biological materialCELULARITY INC·Filed 2018·Application pending·0 cites
- 4359US2024245830A1Multi-layer amniotic tissue grafts and uses thereofCELULARITY INC·Filed 2022·Application pending·0 cites
- 4459US2021121452A1Tumor suppression using human placenta-derived intermediate natural killer cells and immunomodulatory compoundsCELULARITY INC·Filed 2020·Application pending·0 cites
- 4557US2020246385A1Micro-organoids, and methods of making and using the sameCELULARITY INC·Filed 2020·Application pending·0 cites
- 4657US2020138872A1Methods for collecting and using placenta cord blood stem cellsCELULARITY INC·Filed 2019·Application pending·0 cites
- 4757US2021230537A1Angiogenesis using stimulated placental stem cellsCELULARITY INC·Filed 2021·Application pending·0 cites
- 4854US2018237744A1Placental niche and use thereof to culture stem cellsCELULARITY INC·Filed 2017·Application pending·0 cites
- 4954US2019093081A1Placenta-derived intermediate natural killer (pink) cells for treatment of glioblastomaCELULARITY INC·Filed 2018·Application pending·0 cites
- 5053US2020048603A1Cd34+,cd45- placental stem cell-enriched cell populationsCELULARITY INC·Filed 2019·Application pending·0 cites
Showing the top 50 of 72 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CELULARITY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →